| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AEW541 | CCLE | pan-cancer | AAC | 0.14 | 0.003 |
| mRNA | Erlotinib | gCSI | pan-cancer | AAC | 0.16 | 0.004 |
| mRNA | salermide:PLX-4032 (12:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.11 | 0.004 |
| mRNA | OSI-906 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.004 |
| mRNA | elocalcitol | CTRPv2 | pan-cancer | AAC | 0.097 | 0.004 |
| mRNA | AKT inhibitor VIII | GDSC1000 | pan-cancer | AAC | 0.097 | 0.005 |
| mRNA | neratinib | CTRPv2 | pan-cancer | AAC | 0.097 | 0.006 |
| mRNA | WZ8040 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.01 |
| mRNA | QL-XI-92 | GDSC1000 | pan-cancer | AAC | -0.078 | 0.01 |
| mRNA | AZD6244 | CTRPv2 | pan-cancer | AAC | 0.09 | 0.01 |